
zzso containing zzso motifs zzso zzso display a strong zzso activity and drive the immune response toward the zzso zzso helper type 1) zzso These zzso have shown promising efficacy in zzso studies when injected locally in several cancer zzso We conducted a phase 1 trial to define the safety profile of zzso a zzso zzso zzso administered zzso by zzso delivery in patients with zzso zzso zzso of three to six patients were treated with escalating doses of zzso zzso zzso and patients were observed for at least four zzso zzso patients entered the zzso All patients had previously been treated with zzso and most patients had received one or several types of zzso Median age was 58 years zzso zzso and median zzso was zzso zzso zzso zzso effects possibly or probably related to the studied drug were moderate and consisted mainly in worsening of neurological conditions (four zzso fever above 38 degrees C that disappeared within a few days (five zzso and zzso grade 3 zzso zzso zzso Only one patient experienced a zzso zzso zzso evidence of activity was suggested by a minor response observed in two patients and an overall median survival of zzso zzso In conclusion, zzso was well tolerated at doses up to 20 zzso per injection in patients with zzso zzso Main side effects were limited to transient worsening of neurological condition and zzso 

